Algorae Pharmaceuticals Limited
1AI
Rang in Aktien
#31361
Algorae Pharmaceuticals Limited, a company established in 1987 and based in... Algorae Pharmaceuticals Limited, a company established in 1987 and based in Melbourne, Australia, focuses on pioneering pharmaceutical development. Known as Living Cell Technologies Limited until its rebranding in September 2023, the firm primarily conducts research and innovation in living cell technologies within New Zealand. Its development portfolio includes AI-116, a novel combination treatment pairing donepezil with cannabidiol, designed to address various forms of dementia, such as Alzheimer's disease. Another key candidate is AI-168, a unique blend of a cannabinoid and an existing, off-patent drug component, aimed at managing cardiovascular conditions like hypertension. Additionally, Algorae is progressing with NTCELL, an alginate-encapsulated product for the treatment of Parkinson's disease. The company is also collaborating with the University of New South Wales to create AlgaraeOS, an advanced drug discovery platform that utilizes artificial intelligence protocols and extensive data analytics to optimize drug identification and development processes.
Aktienkurs
$0.00634756
Zuletzt synchronisiert: 2026-10-16
Marktkapitalisierung
$12.87M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-37.64%
Land
AU
Handel Algorae Pharmaceuticals Limited (1AI)
Kategorie
Healthcare
Marktkapitalisierung von Algorae Pharmaceuticals Limited(1AI)
Marktkapitalisierung: $12.87M
Mit Stand October 2026 hat Algorae Pharmaceuticals Limited eine Marktkapitalisierung von $12.87M. Das macht Algorae Pharmaceuticals Limited laut unseren Daten zum 31361st wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Algorae Pharmaceuticals Limited von 2004 bis 2026
1AI im Vergleich zu den Top 5 der beliebtesten stocks
